Cargando…
Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy
Glucocorticoids (GCs) are widely used in tumor therapy to reduce tumor growth, inflammation, edema, and other side effects. Controversially, GCs may also cause the progression of highly aggressive pancreatic ductal adenocarcinoma (PDAC). Because microRNA (miR) and autophagy signaling support the inv...
Autores principales: | Liu, Li, Han, Shanshan, Xiao, Xi, An, Xuefeng, Gladkich, Jury, Hinz, Ulf, Hillmer, Stefan, Hoppe-Tichy, Torsten, Xu, Yi, Schaefer, Michael, Strobel, Oliver, Herr, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763328/ https://www.ncbi.nlm.nih.gov/pubmed/36535942 http://dx.doi.org/10.1038/s41419-022-05503-3 |
Ejemplares similares
-
Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1
por: Liu, Li, et al.
Publicado: (2017) -
Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pancreatic Cancer
por: An, Xuefeng, et al.
Publicado: (2021) -
UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis
por: Luo, Yiqiao, et al.
Publicado: (2022) -
Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl
por: Nwaeburu, Clifford C., et al.
Publicado: (2016) -
Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer
por: Zhang, Yiyao, et al.
Publicado: (2015)